Our observation that IL-13 deficient mice are exceptionally resistant to radiation-induced pulmonary fibrosis provides a strong rationale for therapeutic strategies targeting IL-13 to mitigate radiation lung injury. This evidence concerns the gene IL13 and pulmonary fibrosis.